ISO 11607 – Packaging for Medical Devices
ISO 11607 defines the international requirements for packaging systems used to maintain sterility of terminally sterilized medical devices. Although written specifically for medical devices, its principles strongly influence sterile pharmaceutical packaging validation strategies because both industries share the same fundamental objective: maintaining sterile barrier integrity until point of use.
The standard is divided into two primary components. Part 1 focuses on requirements for materials, sterile barrier systems, and packaging system performance. Part 2 addresses validation of forming, sealing, and assembly processes. Together, these sections require manufacturers to demonstrate that the packaging system consistently protects product sterility throughout distribution and storage.
Package integrity testing is central to ISO 11607 compliance. Manufacturers must verify that the sterile barrier system remains intact after sealing, sterilization, transportation simulation, and aging studies. The test method selected must be scientifically justified, reproducible, and capable of detecting defects that compromise sterility.
ISO 11607 emphasizes risk management and objective evidence. Validation documentation must clearly define test methods, acceptance criteria, and ongoing monitoring procedures. Probabilistic methods may be used in certain applications, but deterministic testing technologies provide stronger measurement reliability and improved reproducibility.
Vacuum Decay technology aligns particularly well with ISO 11607 requirements because it offers non-destructive, quantitative evaluation of sterile barrier systems. Its repeatability and measurable output support statistical validation and long-term process control.
Compliance with ISO 11607 requires structured validation protocols, documented performance data, and ongoing verification. Quantitative integrity testing strengthens evidence of sterile barrier performance and supports global regulatory acceptance.